Proleukin (Chiron Corp)
Proleukin (Chiron Corp) Brand names, Proleukin (Chiron Corp) Analogs
Proleukin (Chiron Corp) Brand Names Mixture
- No information avaliable
Proleukin (Chiron Corp) Chemical_Formula
C690H1115N177O202S6
Proleukin (Chiron Corp) RX_link
http://www.rxlist.com/cgi/generic2/aldesleukin.htm
Proleukin (Chiron Corp) fda sheet
Proleukin (Chiron Corp) msds (material safety sheet)
Proleukin (Chiron Corp) Synthesis Reference
No information avaliable
Proleukin (Chiron Corp) Molecular Weight
15314.8
Proleukin (Chiron Corp) Melting Point
No information avaliable
Proleukin (Chiron Corp) H2O Solubility
No information avaliable
Proleukin (Chiron Corp) State
Liquid
Proleukin (Chiron Corp) LogP
-0.192
Proleukin (Chiron Corp) Dosage Forms
Powder for solution
Proleukin (Chiron Corp) Indication
For treatment of adults with metastatic renal cell carcinoma
Proleukin (Chiron Corp) Pharmacology
Used to treat renal cell carcinoma, proleukin induces the enhancement of lymphocyte mitogenesis and stimulation of long-term growth of human interleukin-2 dependent cell lines, the enhancement of lymphocyte cytotoxicity, the induction of killer cell (lymphokine-activated (LAK) and natural (NK)) activity; and the induction of interferon-gamma production. IL-2 is normally produced by the body, secreted by T cells, and stimulates growth and differentiation of T cell response. It can be used in immunotherapy to treat cancer. It enhances the ability of the immune system to kill tumor cells and may interfere with blood flow to the tumor.
Proleukin (Chiron Corp) Absorption
No information avaliable
Proleukin (Chiron Corp) side effects and Toxicity
No information avaliable
Proleukin (Chiron Corp) Patient Information
No information avaliable
Proleukin (Chiron Corp) Organisms Affected
Humans and other mammals
